$APCX
AppTech Payments Corp. Stock $apcx

$apcx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000168316824002017 Filed on April 01, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$76.00K	$141.0K	$504.0K
YoY Change	-43.28%	30.56%	111900.0%
Cost Of Revenue	$14.00K	$28.00K	$187.0K
YoY Change	-77.42%	-47.17%	84900.0%
Gross Profit	$62.00K	$113.0K	$317.0K
YoY Change	-13.89%	105.45%	137726.09%
Gross Profit Margin	81.58%	80.14%	62.9%
Selling, General & Admin	$2.320M	$2.759M	$9.873M
YoY Change	-17.61%	8.75%	123266.24%
% of Gross Profit	3741.94%	2441.59%	3114.51%
Research & Development	$633.0K	$724.0K	$3.498M
YoY Change	27.11%	-64.12%	46188.21%
% of Gross Profit	1020.97%	640.71%	1103.47%
Depreciation & Amortization	$346.0K	$275.0K	$985.0K
YoY Change	18.09%	-32.1%	143.21%
% of Gross Profit	558.06%	243.36%	310.73%
Operating Expenses	$2.953M	$3.483M	$13.37M
YoY Change	-68.73%	-23.53%	81113.56%
Operating Profit	-$2.891M	-$3.370M	-$13.05M
YoY Change	-69.16%	-25.11%	-80511.48%
Interest Expense	-$32.00K	-$4.000K	-$25.00K
YoY Change	-1166.67%	-98.64%	-6095.2%
% of Operating Profit
Other Income/Expense, Net	-$31.00K	$4.000K	$715.0K
YoY Change	-110.69%	-88.57%	1521176.6%
Pretax Income	-$2.922M	-$3.387M	-$18.51M
YoY Change	-67.83%	-28.84%	-113803.09%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.922M	-$3.387M	-$19.28M
YoY Change	-67.83%	-28.84%	-118489.53%
Net Earnings / Revenue	-3844.74%	-2402.13%	-3824.4%
Basic Earnings Per Share	-$0.12		-$1.01
Diluted Earnings Per Share	-$0.12	-$0.16	-$1.01
COMMON SHARES
Basic Shares Outstanding	24.68M shares	20.69M shares	19.10M shares
Diluted Shares Outstanding	24.77M shares		19.10M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.00K	$1.281M	$1.281M
YoY Change	-97.86%	-63.0%	-63.0%
Cash & Equivalents	$16.00K	$1.281M
Short-Term Investments
Other Short-Term Assets	$297.0K	$205.0K	$205.0K
YoY Change	-10.81%	-77.52%	-77.52%
Inventory
Prepaid Expenses	$297.0K	$205.0K
Receivables	$15.00K	$30.00K	$30.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$328.0K	$1.516M	$1.516M
YoY Change	-78.48%	34159.89%	-65.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.00K	$66.00K	$66.00K
YoY Change	-50.52%	-48.03%	-48.03%
Goodwill	$1.161M	$1.161M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$19.00K	$9.000K	$9.000K
YoY Change	111.11%	-99.67%	-99.67%
Total Long-Term Assets	$6.136M	$6.837M	$6.837M
YoY Change	259.67%	84369.98%	-15.53%
TOTAL ASSETS
Total Short-Term Assets	$328.0K	$1.516M	$1.516M
Total Long-Term Assets	$6.136M	$6.837M	$6.837M
Total Assets	$6.464M	$8.353M	$8.353M
YoY Change	100.12%	66622.58%	-33.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.480M	$1.799M	$1.799M
YoY Change	418.83%	518343.8%	418.44%
Accrued Expenses	$1.675M	$536.0K	$536.0K
YoY Change	189.79%	28563.1%	-72.29%
Deferred Revenue
YoY Change
Short-Term Debt	$191.0K	$1.000K	$1.000K
YoY Change	19000.0%	-99.94%	-99.94%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.661M	$4.080M	$4.080M
YoY Change	205.64%	82675.41%	-17.22%
LONG-TERM LIABILITIES
Long-Term Debt	$63.00K	$65.00K	$65.00K
YoY Change	-5.97%	-2.99%	-2.99%
Other Long-Term Liabilities	$0.00	$14.00K	$14.00K
YoY Change	-100.0%	-85.86%	-85.86%
Total Long-Term Liabilities	$63.00K	$79.00K	$79.00K
YoY Change	-46.61%	47490.36%	-52.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.661M	$4.080M	$4.080M
Total Long-Term Liabilities	$63.00K	$79.00K	$79.00K
Total Liabilities	$4.724M	$4.159M	$4.159M
YoY Change	187.52%	81529.05%	-18.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$165.7M	-$159.7M
YoY Change	7.97%	-113821.4%
Common Stock	$25.00K	$22.00K
YoY Change	31.58%	129311.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.740M	$4.194M	$4.194M
YoY Change
Total Liabilities & Shareholders Equity	$6.464M	$8.353M	$8.353M
YoY Change	100.12%	66622.58%	-33.28%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.922M	-$3.387M	-$19.28M
YoY Change	-67.83%	-28.84%	-118489.53%
Depreciation, Depletion And Amortization	$346.0K	$275.0K	$985.0K
YoY Change	18.09%	-32.1%	143.21%
Cash From Operating Activities	-$1.737M	-$2.309M	-$8.859M
YoY Change	-26.58%	-5.83%	-108149.76%
INVESTING ACTIVITIES
Capital Expenditures		-$50.00K	$0.00
YoY Change		-221.95%	-100.0%
Acquisitions
YoY Change
Other Investing Activities		-$500.0K	-$500.0K
YoY Change		24900.0%	24900.0%
Cash From Investing Activities		-$450.0K	-$500.0K
YoY Change		946.51%	-28017.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.966M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	200.0K	3.798M	7.178M
YoY Change	-171.68%	4707.59%	53291.85%
NET CHANGE
Cash From Operating Activities	-1.737M	-2.309M	-8.859M
Cash From Investing Activities		-450.0K	-500.0K
Cash From Financing Activities	200.0K	3.798M	7.178M
Net Change In Cash	-1.537M	1.039M	-2.181M
YoY Change	-41.89%	-143.0%	-9406.99%
FREE CASH FLOW
Cash From Operating Activities	-$1.737M	-$2.309M	-$8.859M
Capital Expenditures		-$50.00K	$0.00
Free Cash Flow		-$2.259M	-$8.859M
YoY Change		-9.39%	397.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001070050
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2023	apcx	Repricing Of Warrants RepricingOfWarrants		usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3498000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7557000	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	27500000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24684317	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	3501
CY2023	dei	Auditor Name AuditorName	dbbmckennon
CY2023	dei	Auditor Firm AuditorFirmId	3501
CY2023	dei	Auditor Location AuditorLocation	San Diego, California
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1281000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3462000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	205000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	183000	usd
CY2023Q4	apcx	Prepaid License Fees Current PrepaidLicenseFeesCurrent	0	usd
CY2022Q4	apcx	Prepaid License Fees Current PrepaidLicenseFeesCurrent	729000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1516000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4425000	usd
CY2023Q4	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	2700000	usd
CY2023Q4	apcx	Note Receivable Current NoteReceivableCurrent	26000	usd
CY2022Q4	apcx	Note Receivable Current NoteReceivableCurrent	26000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	66000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	4428000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	311000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1161000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2023Q4	apcx	Capitalized Prepaid Software Development And License CapitalizedPrepaidSoftwareDevelopmentAndLicense	1147000	usd
CY2022Q4	apcx	Capitalized Prepaid Software Development And License CapitalizedPrepaidSoftwareDevelopmentAndLicense	4921000	usd
CY2023Q4	us-gaap	Assets Assets	8353000	usd
CY2022Q4	us-gaap	Assets Assets	12519000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1799000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	347000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1958000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1870000	usd
CY2023Q4	apcx	Stock Repurchase Liability StockRepurchaseLiability	0	usd
CY2022Q4	apcx	Stock Repurchase Liability StockRepurchaseLiability	430000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	676000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1021000	usd
CY2023Q4	apcx	Notes Payable Related Parties NotesPayableRelatedParties	0	usd
CY2022Q4	apcx	Notes Payable Related Parties NotesPayableRelatedParties	88000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	244000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	433000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	78000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4080000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4929000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	99000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	65000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	67000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	79000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	166000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4159000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5095000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10526	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10526	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	105263158	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	105263158	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16697280	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	22000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	17000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	163921000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	147881000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159749000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-140474000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4194000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7424000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8353000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12519000	usd
CY2023	us-gaap	Revenues Revenues	504000	usd
CY2022	us-gaap	Revenues Revenues	450000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	187000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	220000	usd
CY2023	us-gaap	Gross Profit GrossProfit	317000	usd
CY2022	us-gaap	Gross Profit GrossProfit	230000	usd
CY2023	apcx	Stock Based Compensation Including Selling General And Administrative StockBasedCompensationIncludingSellingGeneralAndAdministrative	2494000	usd
CY2022	apcx	Stock Based Compensation Including Selling General And Administrative StockBasedCompensationIncludingSellingGeneralAndAdministrative	1548000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9873000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8003000	usd
CY2023	apcx	Excess Fair Value Of Equity Issuance Over Assets Received ExcessFairValueOfEquityIssuanceOverAssetsReceived	0	usd
CY2022	apcx	Excess Fair Value Of Equity Issuance Over Assets Received ExcessFairValueOfEquityIssuanceOverAssetsReceived	904000	usd
CY2023	apcx	Stock Based Compensation Including Research And Development StockBasedCompensationIncludingResearchAndDevelopment	982000	usd
CY2022	apcx	Stock Based Compensation Including Research And Development StockBasedCompensationIncludingResearchAndDevelopment	6158000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	19502000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	16464000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-19185000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-16234000	usd
CY2023	us-gaap	Interest Expense InterestExpense	52000	usd
CY2022	us-gaap	Interest Expense InterestExpense	417000	usd
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	27000	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	166000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	715000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	204000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	673000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-47000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18512000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16281000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18512000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16281000	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	763000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19275000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16281000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.00
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19103000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19103000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16246000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16246000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7706000	usd
CY2022	apcx	Antidilution Provision Value AntidilutionProvisionValue	2123000	usd
CY2022	apcx	Common Stock Issued For Forbearance Amount CommonStockIssuedForForbearanceAmount	10000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20000	usd
CY2022	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	407000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13395000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7424000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18512000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3476000	usd
CY2023	apcx	Stock Issued During Period Value For Settlement StockIssuedDuringPeriodValueForSettlement	400000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	33000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8933000	usd
CY2023	apcx	Shares Issued For Debt Extinguishment SharesIssuedForDebtExtinguishment	2440000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4194000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18512000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16281000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3476000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7706000	usd
CY2023	apcx	Expenseloss From Shares Issued For Settlement ExpenselossFromSharesIssuedForSettlement	400000	usd
CY2022	apcx	Expenseloss From Shares Issued For Settlement ExpenselossFromSharesIssuedForSettlement	0	usd
CY2023	apcx	Common Stock Issued For Forbearances Two CommonStockIssuedForForbearancesTwo	-0	usd
CY2022	apcx	Common Stock Issued For Forbearances Two CommonStockIssuedForForbearancesTwo	-10000	usd
CY2023	apcx	Gain On Relief Of Accrued Interest GainOnReliefOfAccruedInterest	0	usd
CY2022	apcx	Gain On Relief Of Accrued Interest GainOnReliefOfAccruedInterest	-150000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2023	apcx	Stock Issued For Excess Fair Value Of Equity StockIssuedForExcessFairValueOfEquity	0	usd
CY2022	apcx	Stock Issued For Excess Fair Value Of Equity StockIssuedForExcessFairValueOfEquity	904000	usd
CY2023	apcx	Cancellation Of Stock Repurchase Liabilities CancellationOfStockRepurchaseLiabilities	430000	usd
CY2022	apcx	Cancellation Of Stock Repurchase Liabilities CancellationOfStockRepurchaseLiabilities	-0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	6131000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	apcx	Gain On Settlement Of Derivative Liabilities GainOnSettlementOfDerivativeLiabilities	-250000	usd
CY2022	apcx	Gain On Settlement Of Derivative Liabilities GainOnSettlementOfDerivativeLiabilities	0	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	47000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	985000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	405000	usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-27000	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-166000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-362000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	38000	usd
CY2023	apcx	Increase Decrease In Prepaid License Costs IncreaseDecreaseInPrepaidLicenseCosts	0	usd
CY2022	apcx	Increase Decrease In Prepaid License Costs IncreaseDecreaseInPrepaidLicenseCosts	180000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	540000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-909000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1809000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	104000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	244000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2023	apcx	Increase Decrease Right Of Use Asset And Liability IncreaseDecreaseRightOfUseAssetAndLiability	-11000	usd
CY2022	apcx	Increase Decrease Right Of Use Asset And Liability IncreaseDecreaseRightOfUseAssetAndLiability	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8859000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8199000	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	-0	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1789000	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	-0	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	2000	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	500000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	-0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-500000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1791000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	88000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	-0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8933000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13488000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1021000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	14000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	679000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	50000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	33000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	20000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7178000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13444000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2181000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3454000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3462000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1281000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3462000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1233000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	apcx	Issuance Of Stock For Intangible Assets IssuanceOfStockForIntangibleAssets	0	usd
CY2022	apcx	Issuance Of Stock For Intangible Assets IssuanceOfStockForIntangibleAssets	407000	usd
CY2023	apcx	Common Stock Issued For Forbearance CommonStockIssuedForForbearance	0	usd
CY2022	apcx	Common Stock Issued For Forbearance CommonStockIssuedForForbearance	10000	usd
CY2023	apcx	Relief Of Antidilution Liability Through Issuance Of Common Stock ReliefOfAntidilutionLiabilityThroughIssuanceOfCommonStock	0	usd
CY2022	apcx	Relief Of Antidilution Liability Through Issuance Of Common Stock ReliefOfAntidilutionLiabilityThroughIssuanceOfCommonStock	2124000	usd
CY2022	apcx	Issuance Of Stock For Prepaid Services IssuanceOfStockForPrepaidServices	269000	usd
CY2023	apcx	Cancellation Of Stock Repurchase Of Liabilities CancellationOfStockRepurchaseOfLiabilities	430000	usd
CY2022	apcx	Cancellation Of Stock Repurchase Of Liabilities CancellationOfStockRepurchaseOfLiabilities	0	usd
CY2023	apcx	Accrual Of Acquisition Consideration AccrualOfAcquisitionConsideration	1500000	usd
CY2022	apcx	Accrual Of Acquisition Consideration AccrualOfAcquisitionConsideration	0	usd
CY2023	apcx	Goodwill From Acquisition GoodwillFromAcquisition	1161000	usd
CY2022	apcx	Goodwill From Acquisition GoodwillFromAcquisition	0	usd
CY2023	apcx	Intangible Assets From Acquisition IntangibleAssetsFromAcquisition	4400000	usd
CY2022	apcx	Intangible Assets From Acquisition IntangibleAssetsFromAcquisition	0	usd
CY2023	apcx	Shares Issued For Loan Extinguishment SharesIssuedForLoanExtinguishment	2440000	usd
CY2022	apcx	Shares Issued For Loan Extinguishment SharesIssuedForLoanExtinguishment	0	usd
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	9.5 to 1 reverse split
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_znBncdx5zLJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86D_z4odZaPInE77">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company makes critical estimates and assumptions in valuing: stock-based awards, intangible assets, identifiable intangible assets from the FinZeo acquisition, and the related goodwill impairment test. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_z8IMU0qqHPA4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_864_zz98O2gFCLKc">Concentration of Credit Risk</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits of $250,000 per institution that pays Federal Deposit Insurance Corporation (“FDIC”) insurance premiums. The Company has never experienced any losses related to these balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounts receivable from merchant services are paid by the financial institutions on a monthly basis. As of December 31, 2023, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zD3lCSCjUYOf">80</span>% of the accounts receivable balance was generated from two customers. As of December 31, 2022, the same two customers accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zig6TXVC28Yf">85</span>% of total accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2023, two customers accounted for a significant amount of our revenues at <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zSbFnK9zybHf">49</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondCustomerMember_zBUvNNsWH0X">31</span>%, respectively. For the year ended December 31, 2022, one customer represented <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zMnj07pgDSml">70</span>% of total revenues. The loss of the customer would have a significant impact on the Company's financials.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6100000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10216672	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5544100	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10216672	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5544100	shares
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1958000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1870000	usd
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	72000	usd
CY2023	apcx	Derivative One Day Loss On Derivative DerivativeOneDayLossOnDerivative	390000	usd
CY2023	apcx	Derivative Gain Loss On Derivative Net1 DerivativeGainLossOnDerivativeNet1	27000	usd
CY2022	apcx	Derivative Gain Loss On Derivative Net1 DerivativeGainLossOnDerivativeNet1	166000	usd
CY2021Q4	apcx	Derivative Liabilities1 DerivativeLiabilities1	599000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	166000	usd
CY2022Q4	apcx	Derivative Liabilities1 DerivativeLiabilities1	433000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	27000	usd
CY2023	apcx	Extinguishment Of Derivative Liability ExtinguishmentOfDerivativeLiability	406000	usd
CY2023Q4	apcx	Derivative Liabilities1 DerivativeLiabilities1	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	90000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	98000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	92000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	85000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	61000	usd
CY2023Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	880000	usd
CY2023	apcx	Gain On Settlement Of Litigation Related To Convertible Note And Warrants GainOnSettlementOfLitigationRelatedToConvertibleNoteAndWarrants	250000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7489960	shares
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4100000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3000000.0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1700000	usd

Files In Submission

Name	View Source	Status
0001683168-24-002017-index-headers.html	Edgar Link	pending
0001683168-24-002017-index.html	Edgar Link	pending
0001683168-24-002017.txt	Edgar Link	pending
0001683168-24-002017-xbrl.zip	Edgar Link	pending
apcx-20231231.xsd	Edgar Link	pending
apptech_ex2101.htm	Edgar Link	pending
apptech_ex2301.htm	Edgar Link	pending
apptech_ex3101.htm	Edgar Link	pending
apptech_ex3102.htm	Edgar Link	pending
apptech_ex3201.htm	Edgar Link	pending
apptech_ex3202.htm	Edgar Link	pending
apptech_ex97.htm	Edgar Link	pending
apptech_i10k-123123.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
apcx-20231231_lab.xml	Edgar Link	unprocessable
apcx-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
apptech_i10k-123123_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
apcx-20231231_cal.xml	Edgar Link	unprocessable
apcx-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APCX
AppTech Payments Corp. Stock $apcx

2024 Q2 Form 10-K Financial Statement

#000168316824002017 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APCX AppTech Payments Corp. Stock $apcx

2024 Q2 Form 10-K Financial Statement

#000168316824002017 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APCX
AppTech Payments Corp. Stock $apcx